GPCR (STOCKS)
Structure Therapeutics Inc. American Depositary Shares
$53.440000
-0.810000 (-1.49%)
Prev close: $54.250000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Raymond C. Stevens
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $3,785.56M
- Employees
- 183
- P/E (TTM)
- -22.07
- P/B (TTM)
- 2.53
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
8
Strong Buy
13
Buy
2
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$-1.22 | $-0.47 | -0.7454 | -157.06% |
|
Sep 2025 (Q3)
|
$-1.11 | $-0.36 | -0.7516 | -209.71% |
|
Jun 2025 (Q2)
|
$-1.08 | $-0.28 | -0.7987 | -283.93% |
|
Mar 2025 (Q1)
|
$-0.81 | $-0.23 | -0.5765 | -246.90% |
Financial Statements
| Revenues | $0.00 |
| Operating Expenses | $176.56M |
| Research and Development | $225.26M |
| Operating Income/Loss | -$176.56M |
| Income/Loss From Continuing Operations After Tax | -$141.20M |
| Income/Loss From Continuing Operations Before Tax | -$140.69M |
| Income Tax Expense/Benefit | $515.00K |
| Income Tax Expense/Benefit, Current | $436.00K |
| Net Income/Loss | -$141.20M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$141.20M |
| Net Income/Loss Available To Common Stockholders, Basic | -$141.20M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.80 |
| Diluted Earnings Per Share | -$0.80 |
| Basic Average Shares | 177,596,000 |
| Diluted Average Shares | 177,596,000 |
| Assets | $1.58B |
| Current Assets | $1.57B |
| Cash | $1.45B |
| Other Current Assets | $124.10M |
| Noncurrent Assets | $13.62M |
| Fixed Assets | $6.65M |
| Other Non-current Assets | $6.96M |
| Liabilities | $67.54M |
| Current Liabilities | $63.29M |
| Accounts Payable | $13.86M |
| Wages | $12.43M |
| Other Current Liabilities | $36.99M |
| Noncurrent Liabilities | $4.26M |
| Equity | $1.52B |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $1.52B |
| Liabilities And Equity | $1.58B |
| Net Cash Flow From Operating Activities | -$222.20M |
| Net Cash Flow From Operating Activities, Continuing | -$222.20M |
| Net Cash Flow From Investing Activities | $89.80M |
| Net Cash Flow From Investing Activities, Continuing | $89.80M |
| Net Cash Flow From Financing Activities | $762.52M |
| Net Cash Flow From Financing Activities, Continuing | $762.52M |
| Net Cash Flow | $630.11M |
| Net Cash Flow, Continuing | $630.11M |
| Comprehensive Income/Loss | -$141.06M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$141.06M |
| Other Comprehensive Income/Loss | $140.00K |
| Other Comprehensive Income/Loss Attributable To Parent | $140.00K |